Cancer Letters
Volume 275, Issue 1 , Pages 9-16 , 8 March 2009

Calcium, calcium-sensing receptor and colon cancer

Received 9 June 2008 ,Revised 9 June 2008 ,Accepted 1 July 2008.

References 

  1. Whitfield JF, Chakravarthy B. Calcium: The Grand-Master Cell Signaller. Ottawa: NRC Research Press; 2001;
  2. Whitfield JF, Bird RP, Chakravarthy BR, Isaacs RJ, Morley P. Calcium: cell cycle regulator, differentiator, killer, chemopreventor, and maybe, tumor promoter. J. Cell. Biochem. Suppl. 1995;22:74–91
  3. Boynton AL, Swierenga SHH, Whitfield JF. The calcium-independence of neoplastic cell proliferation: a promising tool for carcinogen detection. In:  Stich HF,  San RHC editor. Short-Term Tests for Chemical Carcinogens. New York: Springer; 1981;p. 362–371
  4. Swierenga SHH, Whitfield JF, Karasaki S. Loss of proliferative calcium dependence: simple in vitro indicator of tumorigenicity. Proc. Natl. Acad. Sci. USA. 1978;75:6069–6072
  5. Buset M, Lipkin M, Winawer S, Swaroop S, Friedman E. Inhibition of human colonic epithelial cell proliferation in vivo and in vitro by calcium. Cancer Res. 1986;46:5426–5430
  6. Friedman EA. Use of human colonic epithelial cells in tissue culture to study mechanisms of calcium protection. In:  Lipkin M,  Newmak HL,  Kelloff G editor. Calcium, Vitamin D, and Prevention of Colon Cancer. Boca Raton, FL: CRC Press; 1991;p. 159–166
  7. Friedman E, Lipkin M, Winawer S, Buset M, Newmark M. Heterogeneity in the response of familial polyposis epithelial cells and adenomas to increasing levels of calcium in vitro. Cancer. 1989;63:2486–2491
  8. Hebert SC, Cheng S, Geibel J. Functions and roles of the extracellular Ca2+-sensing receptor in the gastrointestinal tract. Cell Calcium. 2004;35:239–247
  9. Holt PH, Bresalier RS, Ma CK, Liu K-F, Lipkin M, Byrd JC, et al. Calcium plus vitamin D alters preneoplastic features of colorectal adenomas and rectal mucosa. Cancer. 2006;106:287–296
  10. Lamprecht SA, Lipkin M. Chemoprevention of colon cancer by calcium, vitamin D and folate: molecular mechanisms. Nature Rev. Cancer. 2003;3:601–613
  11. Lipkin M. Calcium modulation of intermediate biomarkers in the gastrointestinal tract. In:  Lipkin M,  Newmark HL,  Kelloff G editor. Calcium, Vitamin D, and Prevention of Colon Cancer. Boca Raton, FL: CRC Press; 1991;p. 377–420
  12. Lipkin M, Newmark H. Effect of added dietary calcium on colonic epithelial-cell proliferation in subjects at high risk for familial colonic calcium. N. Engl. J. Med. 1985;313:1381–1384
  13. Lipkin M, Newmark H. Calcium and the prevention of colon cancer. J. Cell. Biochem. Suppl. 1995;22:65–73
  14. Pence BC. Role of calcium in colon cancer prevention: experimental and clinical studies. Mutation Res. 1993;290:87–95
  15. Peters U, Chatterjee N, McGlynn KM, Schoen RE, Church TR, Bresalier RS, et al. Calcium intake and colorectal adenoma in a US colorectal cancer early detection program. Am. J. Clin. Nutr. 2004;80:1358–1365
  16. Schatzkin A, Peters U. Advancing the calcium-colorectal cancer hypothesis. J. Natl. Cancer Inst. 2004;96:893–894
  17. Thomas MG, Appleton GVN, Williamson RCN. The inhibitory effect of calcium on colorectal cytokinetics and carcinogenesis. In:  Lipkin M,  Newmark HL,  Kelloff G editor. Calcium, Vitamin D, and Prevention of Colon Cancer. Boca Raton, FL: CRC Press; 1991;p. 173–188
  18. Weingarten MA, Zelmanovici A, Yaphne J. Dietary calcium supplementation for preventing colorecteal cancer and adenomatous polyps. Cochrane Database Syst. Rev. 2008;3:CD003548
  19. Bostick RM, Potter JD, Fosdick L, Grambsch P, Lampe PW, Wood JR, et al. Calcium and colorectal epithelial cell proliferation: a preliminary randomized, double-blinded, placebo-controlled clinical trial. J. Natl. Cancer Inst. 1993;85:132–141
  20. Kleibeuker JH, Welberg JW, Mulder NH, van der Meer R, Cats A, Limburg AJ, et al. Epithelial cell proliferation in the sigmoid colon of patients with adenomatous polyps increases during oral calcium supplementation. Br. J. Cancer. 1993;67:500–503
  21. Brittan M, Wright NA. Stem cell in gastrointestinal structure and neoplastic development. Gut. 2004;53:899–910
  22. Brittan M, Wright NA. The gastrointestinal stem cell. Cell Prolif. 2004;37:35–53
  23. de Santa Barbara P, van den Brink GR, Roberts DJ. Development and differentiation of the intestinal epithelium. Cell. Mol. Life Sci. 2003;60:1322–1332
  24. Marshman E, Booth C, Potten CS. The intestinal epithelial stem cell. BioEssays. 2002;24:91–98
  25. Potten CS, Ellis JR. Adult small intestinal stem cells: identification, location, characteristics, and clinical applications. Ernst Schering Res. Found. Workshop. 2006;60:81–98
  26. Potten CS, Owen G, Booth D. Intestinal stem cells protect their genome by selective segregation of template DNA strands. J. Cell Sci. 2002;115:2381–2388
  27. Roncucci L, Pedroni M, Fante R, Di Gregorio C, Ponz de Leon M. Cell kinetic evaluation of human colonic aberrant crypts. Cancer Res. 1993;53:3726–3729
  28. Yen TH, Wright NA. The gastrointestinal tract stem cell niche. Stem Cell Rev. 2006;2:203–212
  29. Bird RP. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett. 1987;37:147–151
  30. Bird RP, McLelland , Bruce WH. Aberrant crypts, putative precancerous lesions, in the study of the role of diet in the aetiology of colon cancer. Cancer Surv. 1989;8:189–200
  31. McLellan EA, Medline A, Bird RP. Sequential analyses of the growth and morphological characteristics of aberrant crypt foci: putative preneoplastic lesions. Cancer Res. 1991;51:5270–5274
  32. McLellan EA, Medline A, Bird RP. Dose response and proliferative characteristics of aberrant crypt foci: putative preneoplastic lesions in rat colon. Carcinogenesis. 1991;12:2093–2098
  33. Tudek B, Bird RP, Bruce WR. Foci of aberrant crypts in the colons of mice and rats exposed to carcinogens associated with foods. Cancer Res. 1989;49:1236–1240
  34. Whitfield JF, Bird RP, Morley P, Willick GE, Barbier JR, MacLean S, et al. The effects of parathyroid hormone fragments on bone formation and their lack of effects on the initiation of colon carcinogenesis in rats as indicated by preneoplastic aberrant crypt formation. Cancer Lett. 2003;200:107–113
  35. Clevers H. Wnt/β-catenin signaling in development and disease. Cell. 2006;127:469–480
  36. Gregorieff A, Pinto D, Begthel H, Destrée O, Kielman M, Clevers H. Expression pattern of Wnt signaling components in the adult intestine. Gastroenterology. 2005;129:626–638
  37. Gregorieff A, Clevers H. Wnt signaling in the intestinal epithelium: from endoderm to cancer. Genes Dev. 2005;19:877–890
  38. Hoffman J, Kuhnert F, Davis CR, Kuo CJ. Wnts as essential growth factors for the adult small intestine and colon. Cell Cycle. 2004;3:554–557
  39. Holocombe RF, Marsh JL, Waterman ML, Lin F, Milovanovic T, Truong T. Expression of Wnt ligands and Frizzled receptors in colonic mucosa and in colon carcinoma. Mol. Pathol. 2002;55:220–226
  40. Korinek V, Barker N, Moerer P, van Donselaar E, Huls G, Peters PJ, et al. Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nat. Genet. 1998;19:379–383
  41. Kuhnert F, Davis CR, Wang HT, Chu P, Lee M, Yuan J, et al. Essential requirement for Wnt signaling in proliferation of adult small intestine and colon revealed by adenoviral expression of Dickkopf-1. Proc. Natl. Acad. Sci. USA. 2003;101:266–271
  42. Li L, Xie T. Stem cell niche: structure and function. Annu. Rev. Cell Dev. Biol. 2005;21:605–631
  43. Pinto D, Clevers D. Wnt control of stem cells and differentiation in the intestinal epithelium. Exp. Cell Res. 2005;306:357–363
  44. Pinto D, Clevers D. Wnt, stem cells and cancer in the intestine. Biol. Cell. 2005;97:185–196
  45. Pinto D, Gregorieff A, Begthel H, Clevers H. Canonical Wnt signals are essential for homeostasis of the intestinal epithelium. Genes Dev. 2003;15:1709–1713
  46. Su LK, Vogelstein B, Kinzler KW. Association of the APC tumor suppressor proteins with catenins. Science. 1993;262:1734–1737
  47. Pecina-Slaus N. Tumor suppressor gene E-cadherin and its role in normal and malignant cells. Cancer Cell Int. 2003;3:17
  48. Fearnhead NS, Britton MP, Bodmer WF. The ABC of APC. Hum. Mol. Genet. 2001;10:721–733
  49. Näthke I. The adenomatous polyposis coli protein: the Achilles heel of the gut epithelium. Annu. Rev. Cell Dev. Biol. 2004;20:337–366
  50. Näthke I. Cytoskeleton out of the cupboard: colon cancer and cytoskeletal changes induced by loss of APC. Nat. Rev. Cancer. 2006;6:967–974
  51. Näthke I. APC at a glance. J. Cell Sci. 2004;117:4873–4875
  52. Smith KJ, Johnson KA, Bryan TM, Hill DE, Markowitz S, Willson JKV, et al. The APC gene product in normal and tumor cells. Proc. Natl. Acad. Sci. USA. 1993;90:2846–2850
  53. Xiong Y, Kotake Y. No exit strategy? No problem: APC inhibits β-catenin inside the nucleus. Genes Dev. 2006;20:637–642
  54. Kamei J, Toyofuku T, Hori M. Negative regulation of p21 by β-catenin/TCF signaling: a novel mechanism by which cell adhesion molecules regulate cell proliferation. Biochem. Biophys. Res. Commun. 2003;312:380–387
  55. Baumeister W, Walz J, Zühl F, Seemüller E. The proteasome: paradigm of a self-compartmentalizing protease. Cell. 1998;92:367–380
  56. Weinberg RA. The Biology of Cancer. New York: Garland Science; 2006;
  57. Altieri DC. The case for survivin as a regulator of microtubule dynamics and cell-death decisions. Curr. Opin. Cell Biol. 2006;18:609–615
  58. B.M. Boman, T. Zhang, J.Z. Fields, Correspondence re: T. Zhang et al. [57], Cancer Res. 64 (2004) 776–779.
  59. Zhang T, Otevrel T, Gao Z, Gao Z, Ehrlich SM, Fields JZ, et al. Evidence that APC regulates survivin expression: a possible mechanism contributing to the stem cell origin of colon cancer. Cancer Res. 2001;61:8664–8667
  60. Chakrabarty S, Wang H, Canaff L, Hendy GN, Appelman H, Varani J. Calcium sensing receptor in human colon carcinoma: interaction with Ca2+ and the 1,25-dihydroxy vitamin D3. Cancer Res. 2005;65:493–498
  61. Cheng SX, Geibel JP, Hebert SC. Extracellular polyamines regulate fluid secretion in the rat colonic crypts via the extracellular calcium-sensing receptor. Gastroenterology. 2004;126:148–158
  62. Conigrave AD, Mun H-C, Delbridge L, Quinn SJ, Wilkinson M, Brown EM. l-Amino acids regulate parathyroid hormone secretion. J. Biol. Chem. 2004;279:38151–38159
  63. Hebert SC. Therapeutic use of calcimimetics. Annu. Rev. Med. Sci. 2006;57:349–364
  64. Hebert SC, Cheng S, Beibel J. Functions and roles of the extracellular Ca2+-sensing receptor in the gastrointestinal tract. Cell Calcium. 2004;35:239–247
  65. Bhagavathula N, Kelly EA, Reddy M, Nerusu KC, Leonard C, Fay K, et al. Upregulation of calcium-sensing receptor and mitogen-activated protein kinase signalling in the regulation of growth and differentiation in colon carcinoma. Br. J. Cancer. 2005;93:1364–1371
  66. Chakrabarty S, Wang H, Canaff L, Hendy GN, Appelman H, Varani J. Calcium sensing receptor in human colon carcinoma: interaction with Ca2+ and 1,25-dihydroxy vitamin D3. Cancer Res. 2005;65:493–498
  67. Chakrabarty S, Radjendirane V, Appelman H, Varani J. Extracelluar calcium and calcium sensing receptor function in human colon carcinomas: promotion of E-cadherin expression and suppression of β-catenin/TCF activation. Cancer Res. 2003;63:67–71
  68. Tian JQ, Quaroni A. Involvement of p21 (WAF1/CIP1) and p27(Kip 1) in intestinal epithelial cell differentiation. Am. J. Physiol. 1999;276:C1245–C1258
  69. Orsulic S, Huber O, Aberle H, Arnold S, Kemler R. E-cadherin binding prevents β-catenin/LEF-1-mediated transactivation. J. Cell Sci. 1999;112:1237–1245
  70. Whitfield JF. Calcium switches, cell cycles, differentiation, and death. In:  Lipkin M,  Newmark HL,  Kelloff G editor. Calcium, Vitamin D, and Prevention of Colon Cancer. Boca Raton, FL: CRC Press; 1991;p. 31–74
  71. Brenner BM, Russell N, Albrecht S, Davies RJ. The effect of dietary vitamin D3 on the intracellular calcium gradient in mammalian colonic crypts. Cancer Lett. 1998;127:43–53
  72. Hoenderop JGJ, Nilius B, Bindels RJM. Calcium absorption across epithelia. Physiol. Rev. 2004;85:373–422
  73. Renehan AG, O’Dwyer ST, Haboubi NJ, Potten CS. Early events in colorectal carcinogenesis. Colorectal Dis. 2002;4:76–89
  74. Aoki K, Taketo MM. Adenomatous polyposis coli (APC): a multifunctional tumor suppressor gene. J. Cell Sci. 2007;120:3327–3335
  75. Senda T, Shimomura A, Iizuka-Kogo A. Adenomatosis polyposis coli (Apc) tumor suppressor gene as a multifunctional gene. Anat. Sci. Int. 2005;80:121–131
  76. Deng G, Song GA, Pong E, Sleisenger M, Kim YS. Promoter methylation inhibits APC gene expression by causing changes in chromatin conformation and interfering with the binding of transcription factor CCAAT-binding factor. Cancer Res. 2004;64:2692–2698
  77. J. Quian, A.A. Sarnaik, T.M. Bonney, J. Keirsey, K.A. Combs, K. Steigerweald, S. Acharya, G.K. Behbehani, M.C. Barton, A.M. Lowy, J. Groden, The APC tumor suppressor inhibits DNA replication by directly binding to DNA via its carboxy terminus, Gastroenterology April 4 (2008), Epub. ahead of print.
  78. Boquoi A, Enders GH. Adenomatous polyposis coli mutations in colon cancer-slipping off the brake and onto the gas pedal. Cancer Biol. Ther. 2008;7:485–487
  79. Sansom OJ, Reed KR, Hayes AJ, Ireland H, Brinkmann H, Newton IP, et al. Loss pf Apc in vivo immediately perturbs Wnt signaling differentiation and migration. Genes Dev. 2004;18:1385–1390
  80. Tu CL, Chang W, Xie Z, Bikle DD. Inactivation of the calcium-sensing receptor inbits E-cadherin-mediated cell–cell adhesion and calium-induced differentiation in human epidermal keratinocytes. J. Biol. Chem. 2008;283:3519–3528

PII: S0304-3835(08)00529-6

doi: 10.1016/j.canlet.2008.07.001

Cancer Letters
Volume 275, Issue 1 , Pages 9-16 , 8 March 2009

Article Tools

* Image Usage & Resolution